Dermatology appointments now cost $230 out-of-pocket, leaving many Australians to forgo care despite rising skin-cancer rates

The latest Cleanbill health‑directory report, released ahead of the end‑year health spending review, confirms that the average out‑of‑pocket price for a first dermatology appointment for an adult without concessionary rebates has risen to $230, a figure that, when considered alongside the nation’s accelerating skin‑cancer incidence, underscores a paradoxical alignment of rising need and decreasing affordability.

In addition to the headline‑grabbing $230 figure for initial consultations, the analysis indicates that follow‑up visits now command almost $190 on average, while the overall cost of a first appointment has climbed $20 within the preceding twelve months, with the steepest increases recorded in Western Australia, South Australia and Tasmania, thereby highlighting regional disparities that compound the national affordability dilemma.

The head of the Consumers Health Forum has warned that an increasing proportion of Australians are electing to forego medically necessary dermatological examinations, a trend that appears to be a direct consequence of the financial barrier presented by the current pricing structure and which, in the context of soaring skin‑cancer rates, raises serious questions about the efficacy of existing public‑health safeguards.

While Medicare’s schedule of benefits nominally includes dermatology services, the reliance on bulk‑billing exemptions that are unevenly applied across private practices effectively leaves most adult patients without concessions to shoulder the full brunt of private‑sector fees, a procedural inconsistency that betrays the policy’s original intent to ensure equitable access to essential specialist care.

Consequently, the convergence of escalating treatment costs, patchwork concession policies, and a health system that appears more attuned to preserving private‑practice revenue streams than to curbing preventable malignancies signals a predictable, albeit troubling, failure of institutional coordination that is likely to perpetuate the current cycle of denial, delayed diagnosis and avoidable mortality.

Published: April 26, 2026